Carteolol HCl
Brand names,
Carteolol HCl
Analogs
Carteolol HCl
Brand Names Mixture
Carteolol HCl
Chemical_Formula
C16H24N2O3
Carteolol HCl
RX_link
http://www.rxlist.com/cgi/generic2/carteol.htm
Carteolol HCl
fda sheet
Carteolol HCl
msds (material safety sheet)
Carteolol HCl
Synthesis Reference
No information avaliable
Carteolol HCl
Molecular Weight
292.373 g/mol
Carteolol HCl
Melting Point
No information avaliable
Carteolol HCl
H2O Solubility
No information avaliable
Carteolol HCl
State
Solid
Carteolol HCl
LogP
2.037
Carteolol HCl
Dosage Forms
Ophthalmic Solution (1%)
Carteolol HCl
Indication
For the treatment of intraocular hypertension and chronic open-angle glaucoma
Carteolol HCl
Pharmacology
Carteolol is a beta1 and beta2 (non-selective) adrenergic receptor-blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anesthetic (membrane-stabilizing) activity. Carteolol, when applied topically to the eye, has the action of reducing elevated, as well as normal, intraocular pressure, whether or not accompanied by glaucoma. Elevated intraocular pressure is a major risk factor in the pathogenesis of glaucomatous visual field loss and optic nerve damage. Carteolol reduces intraocular pressure with little or no effect on pupil size or accommodation in contrast to the miosis which cholinergic agents are known to produce.
Carteolol HCl
Absorption
No information avaliable
Carteolol HCl
side effects and Toxicity
The most common effects expected with overdosage of a beta-adrenergic blocking agent are bradycardia, bronchospasm, congestive heart failure and hypotension.
Carteolol HCl
Patient Information
No information avaliable
Carteolol HCl
Organisms Affected
Humans and other mammals